#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic sclerosis pulmonary Muscular dystrophy Gastroenteropancreatic neuroendocrine tumour disease Short-bowel syndrome Myelodysplastic syndrome with excess blasts Factor VIII deficiency Hypomagnesaemia Cholangiocarcinoma Oesophageal adenocarcinoma stage III Fungal infection Giant cell tumour of tendon sheath Systemic lupus erythematosus Colitis ulcerative Chordoma Emphysema More trials…

    Learn about Rare Diseases

    Amyotrophic lateral sclerosis – Treatment Ewing’s sarcoma – Life with Disease Pulmonary sarcoidosis – Trials in Disease SAPHO syndrome – Treatment SAPHO syndrome – Life with Disease Vascular malformation – Basic Information Usher’s syndrome Andersen-Tawil syndrome – Diagnostics Angiosarcoma metastatic – Basic Information Mantle cell lymphoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Afimetoran Besilate Dihydrate SOFTISAN 378 Interferon Beta-1A Rilzabrutinib Kpl-404 Amlitelimab Dnth103 Colesevelam Busulfan Brinzolamide Desogestrel Clodronate Disodium Fostemsavir Trometamol ALE.P02 ULIXERTINIB Regn5668 Dronabinol Methionine Anhydrous Docetaxel Lovotibeglogene Autotemcel More therapies…

    Learn about Your Condition

    Ichthyosis Agitation postoperative Eructation Tympanic membrane hyperaemia Vascular malformation Oral neoplasm Sepsis Niemann-Pick disease Myositis Autoimmune haemolytic anaemia Transient ischaemic attack Epileptic encephalopathy Obesity Antithrombin III deficiency Desmoid tumour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Dose optimization study of ibrutinib drug combination in adult patients with haematological diseases

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    • Waldenstrom’s macroglobulinaemia
    Investigated Drugs:
    • Talquetamab
    • Zanubrutinib
    • Ibrutinib
    Denmark

  • Study of REGN7508 versus apixaban for treating and preventing cancer-associated blood clots in adults with solid or blood cancers

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Regn7508
    • Apixaban
    Bulgaria Romania

  • Epcoritamab for Adults with Relapsed or Refractory Marginal Zone Lymphoma: A Phase II Open‑Label Study

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Extranodal marginal zone B-cell lymphoma (MALT type)
    • Splenic marginal zone lymphoma
    • Marginal zone lymphoma
    Investigated Drugs:
    • Epcoritamab
    Germany

  • Long‑Term Effects of Sirolimus on Volume and Color of Port‑Wine Stain in Patients with Vascular Malformation Undergoing Surgery and Laser Therapy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Arteriovenous malformation
    Investigated Drugs:
    • Sirolimus
    Norway

  • Rituximab and venetoclax treatment for 6 vs 26 cycles in patients with relapsed or refractory chronic lymphocytic leukemia

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia recurrent
    • Chronic lymphocytic leukaemia refractory
    • B-cell small lymphocytic lymphoma
    Investigated Drugs:
    • Venetoclax
    The Netherlands

  • Efficacy of efanesoctocog alfa in reducing synovitis in patients with congenital hemophilia A – a multicenter, randomized, open‑label phase 3 trial

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Synovitis
    • Factor VIII deficiency
    Investigated Drugs:
    • Efanesoctocog Alfa
    Austria Germany
Previous Page
1 … 35 36 37 38 39 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!